Sunflower Pharmaceutical Group Co.,Ltd
Sunflower Pharmaceutical Group Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 2001, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, including innovative generics and specialty medications. With a commitment to research and development, Sunflower Pharmaceutical Group focuses on areas such as oncology, cardiology, and neurology, offering unique formulations that cater to diverse patient needs. The company’s dedication to quality and compliance has earned it a strong market position, recognised for its contributions to healthcare advancements. Through strategic partnerships and a robust distribution network, Sunflower continues to expand its reach, making significant strides in improving global health outcomes.
DitchCarbon Score
How does Sunflower Pharmaceutical Group Co.,Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sunflower Pharmaceutical Group Co.,Ltd's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sunflower Pharmaceutical Group Co.,Ltd's reported carbon emissions
Sunflower Pharmaceutical Group Co., Ltd, headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. Consequently, there are no recorded Scope 1, 2, or 3 emissions to analyse. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments towards reducing carbon emissions or addressing climate change. As there is no data inherited from a parent or related organization, all information is based solely on the company's own reporting. Without specific emissions data or reduction initiatives, it is challenging to assess Sunflower Pharmaceutical Group's environmental impact or climate strategy within the pharmaceutical industry context.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sunflower Pharmaceutical Group Co.,Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
